About the Meningioma Session
Meningiomas, while usually benign, pose significant challenges in cancer research due to their diverse biological behavior and potential for recurrence. Researchers are delving into the molecular mechanisms underlying their formation and progression, aiming to identify novel therapeutic targets. Advanced imaging techniques aid in accurate diagnosis and monitoring of tumor growth, while innovative surgical approaches and radiation therapies strive to minimize damage to surrounding brain tissue. Additionally, clinical trials explore the efficacy of targeted therapies and immunotherapies in managing meningiomas, offering hope for improved outcomes and quality of life for patients. Collaborative efforts between clinicians, researchers, and patients are essential in advancing our understanding and treatment of this complex brain tumor.
Topics Covered in Meningioma
Histologic Grading
DNA Methylation Classes
Skull Base Tumors
Active Surveillance
Extent of Resection
Stereotactic Radiosurgery
Related Scientific Sessions at CIOC 2027
Why Attend the Meningioma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Meningioma work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Meningioma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Meningioma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Meningioma Conference 2027 — FAQs
What is the Meningioma track at CIOC 2027?
The Meningioma track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Meningioma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Meningioma sessions?
Cancer researchers and clinicians, educators and students with an interest in Meningioma are all welcome — whether presenting or attending.
Can I present my research in the Meningioma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Meningioma sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Meningioma track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.